Universal (UVV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Nov, 2025Executive summary
Fiscal year 2025 revenue rose 7% year-over-year to $2.95B, with operating income up 5% to $232.8M, despite weather-impacted crops and high green tobacco prices.
Both tobacco and ingredients segments delivered higher revenues and operating income, driven by strong demand and operational execution.
Fourth quarter results declined due to earlier tobacco shipments, with revenue down 9% and operating income down 37% compared to the prior year quarter.
The company declared its 55th consecutive annual dividend increase, with a quarterly dividend of $0.82 per share, annualized at $3.28.
Sustainability initiatives advanced, with significant progress on supply chain transparency and labor standards.
Financial highlights
Q4 FY25 sales and operating revenue were $702.3M, down from $770.9M in Q4 FY24, mainly due to timing shifts in tobacco shipments.
FY25 net income was $95M ($3.78/share), down from $119.6M ($4.78/share) in FY24, mainly due to higher interest expenses and one-time charges.
Adjusted FY25 net income was $116.3M ($4.63/share) vs. $127.1M ($5.08/share) in FY24.
Gross margin for FY25 was 18.6%, up 10 bps year-over-year; Q4 gross margin declined 460 bps to 19.8%.
Net cash from operating activities was $327M, a significant improvement from prior year.
Outlook and guidance
FY26 tobacco demand remains strong, with global flue-cured and burley production expected to rise 20% and 30%, respectively, potentially shifting the market from undersupply to balance or slight oversupply.
Ingredients segment is shifting from platform building to organic growth, supported by recent investments in capacity and product development.
No ongoing legal expenses expected for the Mozambique investigation in FY26.
CapEx for FY26 projected at $45M–$55M, down from $62M in FY25.
Interest expense expected to decrease in FY26 due to normalized working capital and improved cash position.
Latest events from Universal
- Revenue and profit fell, but tobacco stayed strong and liquidity improved with new credit facility.UVV
Q3 20269 Feb 2026 - Q1 FY2025 revenue up 15% and operating income up 56%, with strong demand across segments.UVV
Q1 20252 Feb 2026 - Strategy centers on tobacco leadership, scaling ingredients, and sustainable, profitable growth.UVV
28th Annual ICR Conference 202613 Jan 2026 - Shareholders will vote on directors, executive pay, and auditor ratification amid strong results and ESG progress.UVV
Proxy Filing1 Dec 2025 - Proxy covers director elections, say-on-pay, auditor ratification, and strong ESG focus.UVV
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor, with updated proxy card.UVV
Proxy Filing1 Dec 2025 - Operating income nearly doubled on strong tobacco margins, despite higher costs and tariff risks.UVV
Q1 202623 Nov 2025 - Revenue and net income increased, offsetting margin pressures and supporting growth initiatives.UVV
Q2 202613 Nov 2025 - Digital-first growth, strong Asia expansion, and premium wellness products drive performance.UVV
Investor Presentation27 Jun 2025